Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780961 · ClinicalTrials.gov registry record
Esophageal Cancer Tissue Banking
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 311
- Enrollment target
NCT01780961: Completed study, sponsored by Washington University School of Medicine.
NCT01780961 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 311 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01780961 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 311 participants
- Enrollment target
Study Summary
To create an esophageal cancer biospecimen repository that will collect, annotate, store and distribute human esophageal cancer biospecimens in a manner that embraces the highest ethical standards of human subject's research, that conforms to the best practices of biorepository science and that furthers basic, translational and clinical research in the understanding diagnosis and treatment of this disease.
Primary Outcome
A prospective database which would be maintained in the Division of Cardiothoracic Surgery would be able to link clinical outcomes to processed tissues (pathologic specimens, research specimens and plasma) enabling higher level correlation studies to be performed. Proper use of such a resource will aid considerably in our ability to advance our field and care for our future patients with esophageal cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2011-01-25 |
| Est. Completion | 2021-10-29 |
What the finished NCT01780961 record still lists
NCT01780961 is an observational study that tracks outcomes without assigning an intervention. The registered 311 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01780961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01780961 about?
NCT01780961 is a clinical study titled "Esophageal Cancer Tissue Banking". To create an esophageal cancer biospecimen repository that will collect, annotate, store and distribute human esophageal cancer biospecimens in a manner that embraces the highest ethical standards of human subject's research, that conforms to the best practices of biorepository science and that furt...
What is the current status of trial NCT01780961?
This trial is currently completed. The enrollment target is 311 participants. The study started on 2011-01-25. Estimated completion is 2021-10-29.
Who is sponsoring clinical trial NCT01780961?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI